Literature DB >> 2426198

Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.

P A Manning, M W Heuzenroeder, J Yeadon, D I Leavesley, P R Reeves, D Rowley.   

Abstract

The gene clusters that determine the biosynthesis of both the Inaba and Ogawa serotypes of the O antigen of the lipopolysaccharide of Vibrio cholerae were cloned and expressed in Escherichia coli K-12. Restriction analysis of the clones demonstrated that about 15 kilobases were common to all clones and a further 5 kilobases were common to the Ogawa clones. The O antigens expressed by E. coli K-12 had the specificity of V. cholerae. Antibodies raised against E. coli K-12 that harbor one of these clones, pPM1001 (Inaba), were as highly protective in the infant mouse model system as were antibodies to V. cholerae itself. Introduction of such clones into suitable carrier strains could be expected to produce a good oral immunogen against cholera.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426198      PMCID: PMC260870          DOI: 10.1128/iai.53.2.272-277.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coli, and Salmonella-Escherichia coli hybrid strains.

Authors:  A Hohmann; G Schmidt; D Rowley
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.

Authors:  B Lugtenberg; J Meijers; R Peters; P van der Hoek; L van Alphen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

3.  Cosmids: a type of plasmid gene-cloning vector that is packageable in vitro in bacteriophage lambda heads.

Authors:  J Collins; B Hohn
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation.

Authors:  E J Gangarosa; A Sanati; H Saghari; J C Feeley
Journal:  Lancet       Date:  1967-03-25       Impact factor: 79.321

5.  Immunochemical studies to the O-antigens of vibrio cholerae. Partial characterization of an acid-labile antigenic determinant.

Authors:  J W Redmond; M J Korsch; G D Jackson
Journal:  Aust J Exp Biol Med Sci       Date:  1973-04

6.  Experimental cholera in infant mice: protective effects of antibody.

Authors:  W Chaicumpa; D Rowley
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

7.  Consequences of deletion mutations joining two operons of opposite polarity.

Authors:  M Levinthal; H Nikaido
Journal:  J Mol Biol       Date:  1969-06-28       Impact factor: 5.469

8.  Expanded linkage map of Vibrio cholerae.

Authors:  C Parker; D Gauthier; A Tate; K Richardson; W R Romig
Journal:  Genetics       Date:  1979-02       Impact factor: 4.562

9.  The structure of the O-antigenic side chain of the lipopolysaccharide of Vibrio cholerae 569B (Inaba).

Authors:  J W Redmond
Journal:  Biochim Biophys Acta       Date:  1979-05-01

10.  The 4-amino sugars present in the lipopolysaccharides of vibro cholerae and related vibrios.

Authors:  J W Redmond
Journal:  Biochim Biophys Acta       Date:  1978-09-06
View more
  42 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

Authors:  R K Gupta; S C Szu; R A Finkelstein; J B Robbins
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Bacteriophage Lambda as a Delivery Vector for Tn10-Derived Transposons in Xenorhabdus bovienii.

Authors:  M S Francis; A F Parker; R Morona; C J Thomas
Journal:  Appl Environ Microbiol       Date:  1993-09       Impact factor: 4.792

4.  Mapping of chromosomal loci associated with lipopolysaccharide synthesis and serotype specificity in Vibrio cholerae 01 by transposon mutagenesis using Tn5 and Tn2680.

Authors:  H M Ward; P A Manning
Journal:  Mol Gen Genet       Date:  1989-08

5.  Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139.

Authors:  U H Stroeher; K E Jedani; B K Dredge; R Morona; M H Brown; L E Karageorgos; M J Albert; P A Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Structural and functional characterization of IS1358 from Vibrio cholerae.

Authors:  S Dumontier; P Trieu-Cuot; P Berche
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

7.  Sequence-based classification scheme for the genus Legionella targeting the mip gene.

Authors:  R M Ratcliff; J A Lanser; P A Manning; M W Heuzenroeder
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Genetic characterization of Legionella pneumophila serogroup 1 associated with respiratory disease in Australia.

Authors:  J Lanser; M Adams; R Doyle; P Hewitt; N Sangster
Journal:  Appl Environ Microbiol       Date:  1992-02       Impact factor: 4.792

9.  Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.

Authors:  D F Sigwart; B A Stocker; J D Clements
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

10.  The genome of non-O1 Vibrio cholerae NRT36S demonstrates the presence of pathogenic mechanisms that are distinct from those of O1 Vibrio cholerae.

Authors:  Yuansha Chen; Judith A Johnson; Gordon D Pusch; J Glenn Morris; O Colin Stine
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.